Profile
ProteinQure has built the best computational platform for designing peptides for extra-cellular targets. Its lead program is a peptide drug conjugate for TOP1 resistant solid tumors and is in Phase I and at the best hospitals in North America and has begun dosing. Its platform has been validated (in-vivo and with unprecedented in-vitro characteristics) with four top 25 pharma companies in their experimental assays. ProteinQure is the only computational platform capable of designing peptides with the full complement of non-canonical amino acids, so that our peptides are 100x better than natural peptide ligands. For its own internal programs Protein Qure uses the novel peptides to help deliver payloads in a tissue specific manner. Peptides are ideal for delivery of different payloads like radioisotopes and gene therapy since they are tissue specific and easier to manufacture. ProteinQure also has exciting in-vivo POC for siRNA delivery to CNS.
Website
proteinqure.comContact
-
Lucas Siow, Chief Executive OfficerTel: +1 647-248-9772Email: lucas@proteinqure.com
-
-
-
-
-
Event details
Event contact
Participants
-
20/20 OptimEyes Technologies has developed a mucoadhesive drug delivery platform technology that allows for… -
BioBackers is a nascent investor intelligence platform for therapeutics companies raising capital. The platform… -
BioScript Solutions is a Canadian healthcare company committed to simplifying access to specialty care. It… -
Bough Biosciences is a pre-seed stage biotech focused on the development of a therapy for treatment resistant… -
HDAX Therapeutics, a biotechnology company pioneering a novel approach to target… -
iCLASS is a revolutionary TechBIO company merging multi-proteomics-centered data generation with next-generation… -
Intrepid Labs revolutionizes drug formulation with Valiant™, an AI-driven robotic lab that explores… -
JN Nova Pharma is Canadian biotech company which has worked with National Research Council of Canada… -
Noa Therapeutics is pioneering a novel biased signal approach to AhR… -
Pattern’s patented PPI-100 activates innate immunity against cancers… -
PlantForm Corporation is a biopharmaceutical company focused on the rapid development and production of specialty… -
ProteinQure has built the best computational platform for designing peptides for extra-cellular targets. Its lead…
-
Q&C Services is Canada’s largest independent full-service consultant and importer for pharmaceutical, natural… -
QurCan Therapeutics is advancing the next wave of genetic medicines for CNS… -
Rhythm Biotherapeutics develops first-in-class, heart-derived exosome therapeutics to prevent atrial fibrillation… -
Singularity Pharma is a drug discovery business developing novel therapeutics for… -
Specific Biologics is developing Dualase®, an industry-leading genome editing platform with best-in-class… -
Spiderwort is a platform biomaterials company developing a suite of cellulose-based scaffolds for use in a number… -
TheraVac Biologics is a late-stage preclinical company developing innovative immunotherapies for… -
Transpharmation is a contract research organisation led by scientists. Recognised by drug developers worldwide… -
Virano is a genetic immunomodulation company, developing next-generation combination products which reprogram the… -
YYZ Pharmatech Inc. (“YYZ”) is a deep tech company endeavoring to profoundly progress new medicine…